Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007368 |
---|---|
Receipt number | R000008675 |
Scientific Title | Phase II study of TS-1+Trastuzumab in HER2-positive advanced gastric cancer patients more than 65 years old |
Date of disclosure of the study information | 2012/02/23 |
Last modified on | 2018/03/08 08:46:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/23 17:26:32 | ||
2 | Update | 2012/03/01 13:38:01 | Recruitment status |
|
3 | Update | 2013/05/03 08:31:11 | Email |
|
4 | Update | 2013/08/23 09:08:08 | Last name of lead principal investigator Organization Division name TEL Last name of contact person Last name of contact person |
|
5 | Update | 2013/11/20 11:34:42 | Last name of contact person Last name of contact person Institutions |
|
6 | Update | 2013/11/20 12:59:21 | Last name of contact person Last name of contact person |
|
7 | Update | 2014/02/23 14:46:04 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2014/08/23 09:24:47 | Recruitment status |
|
9 | Update | 2016/11/15 13:14:11 | Key inclusion criteria |
|
10 | Update | 2016/11/15 13:19:14 | Name of primary person or sponsor Organization Organization |
|
11 | Update | 2016/11/15 13:20:31 | Date trial data considered complete Date analysis concluded Publication of results |
|
12 | Update | 2018/03/08 08:46:31 | Recruitment status Publication of results |